BUY Polycab India Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))13 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Polycab India Limited announced its Q1 FY27 financial results, reporting the highest ever first quarter revenue, EBITDA, and profitability. Revenue grew 39% YoY to ₹82,097 Million, EBITDA increased 32
NSE · Press Release·16 Jul · today
Polycab India announced its Q1 FY27 financial results, reporting highest ever first quarter revenue, EBITDA, and profitability. Revenue grew 39% YoY to ₹82,097 Million, EBITDA grew 32% YoY to ₹11,362
BSE · Company Update·16 Jul · today
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·16 Jul · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Polycab India
- BUY — Jefferies India16 Oct 2026 · ~1 year · target ₹11,040 · Active
- BUY — BOB Capital Markets16 Oct 2026 · ~1 year · target ₹10,100 · Active
- BUY — Anand Rathi16 Oct 2026 · ~1 year · target ₹10,877 · Active
- BUY — Motilal Oswal16 Oct 2026 · ~1 year · target ₹10,600 · Active
- BUY — Nuvama Wealth16 Oct 2026 · ~1 year · target ₹10,000 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

